Merck & Co's Irish project receives extra €20 million
This article was originally published in Scrip
Executive Summary
Merck Sharp & Dohme has announced an additional €20 million investment for the first phase of construction of the company's new vaccines and biologics facility in Carlow, Ireland. This brings the total investment for the project to €220 million, the company says.